Work

A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies

Year: 2022

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2022-157400

Authors: Sattva S. Neelapu, Don A. Stevens, Mehdi Hamadani, Matthew J. Frank, Houston Holmes, Aya Jacobovits, John Hinkle, Jackie Kennedy-Wilde, Ori Maller, Bayarmagnai Weinstein, Francesco Galimi, Rose K. Lai, David B. Miklos

Institutions: The University of Texas MD Anderson Cancer Center, Norton Healthcare, Norton Hospital, Medical College of Wisconsin, Stanford Medicine, Stanford University, The University of Texas at Austin

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310107594

FWCI: 2.348

Cites:

Cited by: 33

Related to: 10